Research ExplorerPublications[Value of SPECT-immunoscintigraphy in radiation treatment pl...

[Value of SPECT-immunoscintigraphy in radiation treatment planning for patients with squamous cell carcinomas in the head and neck area]

Standard

[Value of SPECT-immunoscintigraphy in radiation treatment planning for patients with squamous cell carcinomas in the head and neck area]. / Adamietz, I A; Schemmann, F; Baum, R P; Knecht, Rainald; Saran, F; Mose, S; Thilmann, C; Hör, G; Böttcher, H D.

In: STRAHLENTHER ONKOL, Vol. 171, No. 5, 5, 1995, p. 278-283.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Adamietz, IA, Schemmann, F, Baum, RP, Knecht, R, Saran, F, Mose, S, Thilmann, C, Hör, G & Böttcher, HD 1995, '[Value of SPECT-immunoscintigraphy in radiation treatment planning for patients with squamous cell carcinomas in the head and neck area]', STRAHLENTHER ONKOL, vol. 171, no. 5, 5, pp. 278-283. <http://www.ncbi.nlm.nih.gov/pubmed/7770783?dopt=Citation>

APA

Adamietz, I. A., Schemmann, F., Baum, R. P., Knecht, R., Saran, F., Mose, S., Thilmann, C., Hör, G., & Böttcher, H. D. (1995). [Value of SPECT-immunoscintigraphy in radiation treatment planning for patients with squamous cell carcinomas in the head and neck area]. STRAHLENTHER ONKOL, 171(5), 278-283. [5]. http://www.ncbi.nlm.nih.gov/pubmed/7770783?dopt=Citation

Vancouver

Adamietz IA, Schemmann F, Baum RP, Knecht R, Saran F, Mose S et al. [Value of SPECT-immunoscintigraphy in radiation treatment planning for patients with squamous cell carcinomas in the head and neck area]. STRAHLENTHER ONKOL. 1995;171(5):278-283. 5.

Bibtex

@article{98227ed06d65414693a8c33d1aeaf1cd,
title = "[Value of SPECT-immunoscintigraphy in radiation treatment planning for patients with squamous cell carcinomas in the head and neck area]",
abstract = "PURPOSE: Introduction of monoclonal antibodies (immunoscintigraphy) has significantly extended the diagnostic spectrum of nuclear medicine in oncology. The detection rate of this new method in patients bearing squamous cell carcinoma of head and neck is better compared to computed tomography and magnetic resonance imaging. In a prospective study, we examined whether immunoscintigraphy in addition to other imaging procedures is able to provide additional diagnostic information for radiation treatment planning.",
author = "Adamietz, {I A} and F Schemmann and Baum, {R P} and Rainald Knecht and F Saran and S Mose and C Thilmann and G H{\"o}r and B{\"o}ttcher, {H D}",
year = "1995",
language = "Deutsch",
volume = "171",
pages = "278--283",
journal = "STRAHLENTHER ONKOL",
issn = "0179-7158",
publisher = "Urban und Vogel",
number = "5",

}

RIS

TY - JOUR

T1 - [Value of SPECT-immunoscintigraphy in radiation treatment planning for patients with squamous cell carcinomas in the head and neck area]

AU - Adamietz, I A

AU - Schemmann, F

AU - Baum, R P

AU - Knecht, Rainald

AU - Saran, F

AU - Mose, S

AU - Thilmann, C

AU - Hör, G

AU - Böttcher, H D

PY - 1995

Y1 - 1995

N2 - PURPOSE: Introduction of monoclonal antibodies (immunoscintigraphy) has significantly extended the diagnostic spectrum of nuclear medicine in oncology. The detection rate of this new method in patients bearing squamous cell carcinoma of head and neck is better compared to computed tomography and magnetic resonance imaging. In a prospective study, we examined whether immunoscintigraphy in addition to other imaging procedures is able to provide additional diagnostic information for radiation treatment planning.

AB - PURPOSE: Introduction of monoclonal antibodies (immunoscintigraphy) has significantly extended the diagnostic spectrum of nuclear medicine in oncology. The detection rate of this new method in patients bearing squamous cell carcinoma of head and neck is better compared to computed tomography and magnetic resonance imaging. In a prospective study, we examined whether immunoscintigraphy in addition to other imaging procedures is able to provide additional diagnostic information for radiation treatment planning.

M3 - SCORING: Zeitschriftenaufsatz

VL - 171

SP - 278

EP - 283

JO - STRAHLENTHER ONKOL

JF - STRAHLENTHER ONKOL

SN - 0179-7158

IS - 5

M1 - 5

ER -